What does VLS stand for?

Vascular Leak Syndrome (medical disorder)

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Voluntary Load Reduction Program (energy reduction) Variable Level Rail System Variable-Length Re-Writing System Virginia Lawyer Referral Service (est. 1977) Virtual Line Replaceable Unit Volunteering Logan River Valley (Creastmead, Australia) Valley Library Consortium (Saginaw, Michigan) Vandenberg Launch and Landing Site Vapor-Liquid-Solid Variable Low Speed		Vehicle Lease and Service Limited (UK) Vélos en Libre Service (French: free bicycling service) Vertical Launch System Vertical Lay System (subsea production wells) Very Long Shot Vinyl Single Virtual Learning Space Virtual Library System Volunteer Life Saving Corps Victorian Local Sustainability Accord (Australia)

Samples in periodicals archive:

Next is a chapter on C1-inhibitor therapy in animal models and in clinical diseases, focusing on hereditary angioedema, sepsis, vascular leak syndrome, and acute myocardial infarction.

Therapeutic Interventions in the Complement System

Vitetta and her colleagues encountered vascular leak syndrome when they began testing immunotoxins in cancer patients.

Stopping leaks may boost cancer drugs

The vaccine candidate, which is being developed in collaboration with UT Southwestern, is a modified subunit of the native ricin toxin which has been genetically engineered to eliminate both its enzymatic activity and its ability to induce vascular leak syndrome (VLS).

DOR BioPharma, Inc. Provides Update on Ricin Vaccine Development ...

The vaccine candidate consists of one of the two subunits of the ricin toxin, which has been genetically engineered to eliminate both its enzymatic activity and its ability to induce vascular leak syndrome (VLS).

DOR BioPharma Executes Exclusive Worldwide License Agreement For ...

AMEX:DOR, "DOR" or the "Company") announced the publication of a paper in Nature Biotechnology (2003 21:387) describing a point mutation of ricin toxin that eliminates vascular leak syndrome (VLS), one of the major toxicities of ricin toxin.

DOR BioPharma Announces Publication of Article Concerning Ricin ...

6,566,500, which contains key claims relating to structural modifications of ricin A chain that abolish vascular leak syndrome (VLS).

DOR BioPharma Announces Issuance of Patent for Recombinant Ricin A ...

Adverse events included one case of vascular leak syndrome.

Ligand's ONTAK Demonstrates Potential to Treat Steroid-Resistant ...

The vaccine candidate consists of only one of the two subunits of the ricin toxin which has been genetically engineered to eliminate both its enzymatic activity and its ability to induce vascular leak syndrome (VLS).

DOR BioPharma Executes Option for Non-Toxic Ricin Vaccine Technology ...